Sama Carley, MD
MOHS-Micrographic Surgery · Santee, CANPI 1487018263
Payments from drug & device makers
Across 109 payments — averaging $28.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$808
- Incyte Corporation$466
- Johnson & Johnson$316
- Lilly USA, LLC$268
- Pfizer$212
- E.r. Squibb & Sons, L.L.C.$175
- plus $876 from 10 others
What the payments were for
- Food & beverage$2,14969%
- Education$1996%
- Other$77425%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 8 | $808 |
| Incyte Corporation | 29 | $466 |
| Johnson & Johnson | 12 | $316 |
| Lilly USA, LLC | 13 | $268 |
| Pfizer | 15 | $212 |
| E.r. Squibb & Sons, L.L.C. | 5 | $175 |
| UCB, Inc. | 10 | $169 |
| Sanofi | 2 | $161 |
| Neurocrine Biosciences, Inc. | 1 | $152 |
| Bristol Myers Squibb | 1 | $125 |
| AbbVie | 6 | $110 |
| Polynovo North America LLC | 2 | $57 |
| Arcutis Biotherapeutics, Inc. | 2 | $37 |
| LEO Pharma Inc. | 1 | $29 |
| Bausch & Lomb Americas Inc. | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,122 in reported general payments places this provider in the 55th percentile of 144 mohs-micrographic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acitretin | 14 | $2,429 |
| Cefadroxil | 150 | $776 |
| Triamcinolone Acetonide | 12 | $719 |
| Clindamycin Phosphate | 16 | $454 |
| Doxycycline Monohydrate | 25 | $400 |
| Doxycycline Hyclate | 21 | $211 |
| Mupirocin | 18 | $185 |
| Ciprofloxacin Hcl | 21 | $149 |
| Tramadol Hcl | 13 | $45 |
| Lorazepam | 16 | $37 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Santee
- Michael MortazieOrange$1.2M
- Thuzar ShinSacramento$353K
- Sarah ArronBurlingame$223K
- Christopher Crosbyla Mesa$211K
- Abel TorresLoma Linda$136K
- Robert ScheinbergOceanside$129K
- Sherry RotundaOceanside$99K
- Sumaira AasiStanford$66K
- Daniel Zelacla Jolla$43K
- Ralph MasseySanta Monica$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.